- Home
- ANIK vs CNTX Comparison
ANIK vs CNTX Comparison
Compare ANIK & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ANIK | CNTX |
|---|---|---|
| Founded | 1983 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 134.8M | 132.3M |
| IPO Year | 1993 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ANIK | CNTX |
|---|---|---|
| Price | $10.33 | $2.26 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $16.00 | $6.00 |
| AVG Volume (30 Days) | 162.9K | ★ 2.2M |
| Earning Date | 03-11-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $112,806,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.79 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 30.55 | N/A |
| 52 Week Low | $7.87 | $0.49 |
| 52 Week High | $18.37 | $2.85 |
Technical Indicators
Market Signals| Indicator | ANIK | CNTX |
|---|---|---|
| Relative Strength Index (RSI) | 66.95 | 62.77 |
| Support Level | $9.01 | $2.06 |
| Resistance Level | $10.95 | $2.85 |
| Average True Range (ATR) | 0.33 | 0.28 |
| MACD | 0.14 | 0.01 |
| Stochastic Oscillator | 76.29 | 57.53 |
Price Performance
Historical ComparisonAbout ANIK Anika Therapeutics Inc.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.